US6331543B1
(en)
|
1996-11-01 |
2001-12-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
|
DE19752952A1
(de)
|
1997-11-28 |
1999-06-02 |
Merck Patent Gmbh |
Thienopyrimidine
|
US6410584B1
(en)
|
1998-01-14 |
2002-06-25 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells with indole derivatives
|
US6248308B1
(en)
*
|
1998-04-14 |
2001-06-19 |
Sepracor Inc. |
Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma
|
DE19819023A1
(de)
|
1998-04-29 |
1999-11-04 |
Merck Patent Gmbh |
Thienopyrimidine
|
US6200771B1
(en)
|
1998-10-15 |
2001-03-13 |
Cell Pathways, Inc. |
Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
|
US6133271A
(en)
*
|
1998-11-19 |
2000-10-17 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
|
US6187779B1
(en)
|
1998-11-20 |
2001-02-13 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives
|
US6369092B1
(en)
|
1998-11-23 |
2002-04-09 |
Cell Pathways, Inc. |
Method for treating neoplasia by exposure to substituted benzimidazole derivatives
|
US6034099A
(en)
*
|
1998-11-24 |
2000-03-07 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones
|
US6077842A
(en)
*
|
1998-11-24 |
2000-06-20 |
Cell Pathways, Inc. |
Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives
|
US6486155B1
(en)
|
1998-11-24 |
2002-11-26 |
Cell Pathways Inc |
Method of inhibiting neoplastic cells with isoquinoline derivatives
|
US6020379A
(en)
*
|
1999-02-19 |
2000-02-01 |
Cell Pathways, Inc. |
Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia
|
EP1323719A1
(en)
*
|
1999-03-30 |
2003-07-02 |
Nippon Soda Co., Ltd. |
Thienopyrimidine compounds and salts thereof and process for the preparation of the same
|
DE19928146A1
(de)
|
1999-06-19 |
2000-12-21 |
Merck Patent Gmbh |
Thienopyrimidine
|
DE19942474A1
(de)
*
|
1999-09-06 |
2001-03-15 |
Merck Patent Gmbh |
Pyrazolo[4,3-d]pyrimidine
|
DE19943815A1
(de)
*
|
1999-09-14 |
2001-03-15 |
Merck Patent Gmbh |
Verwendung von Thienopyrimidinen
|
DE19944604A1
(de)
*
|
1999-09-17 |
2001-03-22 |
Merck Patent Gmbh |
Aminderivate
|
DE10001021A1
(de)
*
|
2000-01-13 |
2001-07-19 |
Merck Patent Gmbh |
Pharmazeutische Zubereitung
|
DE10031585A1
(de)
*
|
2000-06-29 |
2002-01-10 |
Merck Patent Gmbh |
2-Aminoalkyl-thieno[2,3-d]pyrimidine
|
DE10031584A1
(de)
*
|
2000-06-29 |
2002-01-10 |
Merck Patent Gmbh |
5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
|
DE10042997A1
(de)
*
|
2000-09-01 |
2002-03-14 |
Merck Patent Gmbh |
Thienopyrimidine
|
EP1329454A1
(en)
*
|
2000-09-29 |
2003-07-23 |
Nippon Soda Co., Ltd. |
Thienopyrimidine compounds and their salts and process for preparation of both
|
DE10064994A1
(de)
*
|
2000-12-23 |
2002-07-04 |
Merck Patent Gmbh |
Sulfamidothienopyrimidine
|
DE10103647A1
(de)
|
2001-01-27 |
2002-08-01 |
Merck Patent Gmbh |
Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates
|
BR0116849A
(pt)
*
|
2001-01-31 |
2004-02-25 |
Merck Patent Gmbh |
Formulações farmacêuticas compreendendo pirazolo[4,3-d]pirimidinas e nitratos ou tienopirimidinas e nitratos
|
CA2437085A1
(en)
*
|
2001-02-02 |
2002-08-15 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists
|
US6849638B2
(en)
*
|
2001-04-30 |
2005-02-01 |
Bayer Pharmaceuticals Corporation |
4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of pde7b-mediated diseases and conditions
|
DE10148883A1
(de)
*
|
2001-10-04 |
2003-04-10 |
Merck Patent Gmbh |
Pyrimidinderivate
|
WO2003035653A1
(fr)
*
|
2001-10-26 |
2003-05-01 |
Nippon Soda Co.,Ltd. |
Compose pyridothienopyrimidine et son sel
|
US7208516B2
(en)
|
2002-03-20 |
2007-04-24 |
Celgene Corporation |
Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
|
US7276529B2
(en)
|
2002-03-20 |
2007-10-02 |
Celgene Corporation |
Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
|
US6962940B2
(en)
|
2002-03-20 |
2005-11-08 |
Celgene Corporation |
(+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
|
US7893101B2
(en)
|
2002-03-20 |
2011-02-22 |
Celgene Corporation |
Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
|
DE10224462A1
(de)
*
|
2002-06-03 |
2003-12-11 |
Bayer Ag |
Verwendung von cGMP stimulierenden Verbindungen
|
JP2004137270A
(ja)
*
|
2002-09-26 |
2004-05-13 |
Nippon Nohyaku Co Ltd |
新規除草剤、その使用方法、新規置換チエノピリミジン誘導体及びその中間体並びにそれらの製造方法
|
TW200410975A
(en)
*
|
2002-09-26 |
2004-07-01 |
Nihon Nohyaku Co Ltd |
New pesticide and method for using it, new substituted thienopyrimidine derivative, its intermediate, and method for producing it
|
ES2217956B1
(es)
*
|
2003-01-23 |
2006-04-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de 4-aminotieno(2,3-d)pirimidin-6-carbonitrilo.
|
MXPA05011643A
(es)
|
2003-04-29 |
2005-12-15 |
Pfizer Ltd |
5,7-diaminopirazolo[4,3-d]pirimidinas en el tratamiento de hipertension.
|
DE10351436A1
(de)
*
|
2003-11-04 |
2005-06-09 |
Merck Patent Gmbh |
Verwendung von Thienopyrimidinen
|
US7572799B2
(en)
|
2003-11-24 |
2009-08-11 |
Pfizer Inc |
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
|
GB0327323D0
(en)
*
|
2003-11-24 |
2003-12-31 |
Pfizer Ltd |
Novel pharmaceuticals
|
CA2562251C
(en)
|
2004-04-07 |
2009-04-28 |
Pfizer Inc. |
Pyrazolo'4,3-d pyrimidines
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
ES2259891B1
(es)
*
|
2004-11-30 |
2007-11-01 |
Laboratorios Almirall S.A. |
Nuevos derivados de piridotienopirimidina.
|
ES2259892B1
(es)
*
|
2004-11-30 |
2007-11-01 |
Laboratorios Almirall S.A. |
Nuevos derivados de piridotienopirimidina.
|
US8506934B2
(en)
|
2005-04-29 |
2013-08-13 |
Robert I. Henkin |
Methods for detection of biological substances
|
AU2006258461B2
(en)
*
|
2005-06-14 |
2011-08-25 |
Aska Pharmaceutical Co., Ltd. |
Thienopyrimidine derivative
|
US20070099941A1
(en)
*
|
2005-11-02 |
2007-05-03 |
Cytovia, Inc. |
N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
US20070213305A1
(en)
*
|
2005-11-02 |
2007-09-13 |
Cytovia, Inc. |
N-alkyl-N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
US20070099877A1
(en)
*
|
2005-11-02 |
2007-05-03 |
Cytovia, Inc. |
N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
AU2006311577B2
(en)
|
2005-11-09 |
2013-02-07 |
Zalicus Inc. |
Methods, compositions, and kits for the treatment of medical conditions
|
US20090182140A1
(en)
*
|
2005-12-02 |
2009-07-16 |
Mitsubishi Tanabe Pharma Corporation |
Alicyclic Heterocyclic Compound
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
US8293489B2
(en)
|
2007-01-31 |
2012-10-23 |
Henkin Robert I |
Methods for detection of biological substances
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
AU2008297876B2
(en)
|
2007-09-14 |
2011-07-07 |
Addex Pharma S.A. |
1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
|
CN103342695B
(zh)
|
2007-09-14 |
2015-04-22 |
杨森制药有限公司 |
1’,3’-二取代的-4-苯基-3,4,5,6-四氢-2h,1’h-[1,4’]二吡啶-2’-酮
|
NZ585348A
(en)
*
|
2007-10-19 |
2012-02-24 |
Boehringer Ingelheim Int |
Heterocycle-substituted piperazino-dihydrothienopyrimidines
|
US8580801B2
(en)
|
2008-07-23 |
2013-11-12 |
Robert I. Henkin |
Phosphodiesterase inhibitor treatment
|
BRPI0918055A2
(pt)
|
2008-09-02 |
2015-12-01 |
Addex Pharmaceuticals Sa |
derivados de 3-azabiciclo[3,1,0]hexila como moduladores de receptores metabotrópicos de glutamato.
|
MX2011005242A
(es)
|
2008-11-28 |
2011-09-06 |
Ortho Mcneil Janssen Pharm |
Derivados de indol y benzoxazina como moduladores de los receptores de glutamato metabotropicos.
|
MY161325A
(en)
|
2009-05-12 |
2017-04-14 |
Janssen Pharmaceuticals Inc |
1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
|
AR076859A1
(es)
|
2009-05-12 |
2011-07-13 |
Ortho Mcneil Janssen Pharm |
Derivados de 1,2,4-triazolo[4,3-a]piridina moduladores alostericos positivos de receptores mglur2 , composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos neurologicos y siquiatricos.
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
KR101147550B1
(ko)
*
|
2009-10-22 |
2012-05-17 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 가지는 2,7-치환된 티에노[3,2-d]피리미딘 화합물
|
PE20130184A1
(es)
*
|
2010-02-17 |
2013-03-09 |
Takeda Pharmaceutical |
Compuesto heterociclico
|
WO2012062750A1
(en)
|
2010-11-08 |
2012-05-18 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
ES2552879T3
(es)
|
2010-11-08 |
2015-12-02 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
ES2536433T3
(es)
|
2010-11-08 |
2015-05-25 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
MX2014000648A
(es)
|
2011-07-19 |
2014-09-25 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y sus usos.
|
EP2804603A1
(en)
|
2012-01-10 |
2014-11-26 |
President and Fellows of Harvard College |
Beta-cell replication promoting compounds and methods of their use
|
US20150297601A1
(en)
|
2012-10-05 |
2015-10-22 |
Robert I. Henkin |
Phosphodiesterase inhibitor treatment
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
CN106061504B
(zh)
|
2014-01-21 |
2019-09-06 |
詹森药业有限公司 |
包括代谢型谷氨酸能受体亚型2的正别构调节物或正位激动剂的组合及其用途
|
KR20200126026A
(ko)
|
2014-01-21 |
2020-11-05 |
얀센 파마슈티카 엔.브이. |
대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
|
CN106233141B
(zh)
|
2014-02-18 |
2018-08-21 |
罗伯特·I·汉金 |
用于诊断和治疗味觉或嗅觉的损失和/或失真的方法和组合物
|
JP6687550B2
(ja)
|
2014-06-23 |
2020-04-22 |
セルジーン コーポレイション |
肝疾患又は肝機能異常を治療するためのアプレミラスト
|
SG11201804901WA
(en)
|
2015-12-22 |
2018-07-30 |
SHY Therapeutics LLC |
Compounds for the treatment of cancer and inflammatory disease
|
CA3049816A1
(en)
|
2017-01-22 |
2018-07-26 |
North & South Brother Pharmacy Investment Company Limited |
Thienopyrimidine derivative and use thereof in medicine
|
CN111032662A
(zh)
|
2017-06-21 |
2020-04-17 |
尚医治疗有限责任公司 |
与ras超家族相互作用的用于治疗癌症、炎性疾病、ras蛋白病和纤维化疾病的化合物
|